Epilepsy is the second most common neurological condition worldwide, after headaches.In Ontario, it affects 76,000 people.

The disorder causes seizures of varying kinds and intensity. But people with epilepsy must also live with other devastating results of their illness: the social stigma associated with seizures, difficulty finding employment, loss of driving privileges, cognitive decline and memory impairment, and higher mortality rates. The cost to society is also significant. A recent study estimated that the Ontario economy loses $319 million every year in lost productivity due to epilepsy.

The Ontario Brain Institute challenged neuroscientists across the province to come up with a new approach to addressing epilepsy, in the context of an Integrated Discovery program. “Integrated Discovery” is a unique template, developed by the OBI, that brings together researchers, clinicians, industry and patient advocates to maximize fresh insights and speed translation of those insights into better care.


The Epilepsy Research Program of the Ontario Brain Institute (EpLink) is a research-based innovative initiative designed to improve the care of epilepsy from diagnosis to treatment. The program’s mandate is to ensure that discoveries are transformed into new diagnostics, treatments and improved clinical practice. The emphasis is on translational science and involves a province-wide collaboration between Ontario’s world-class epilepsy researchers and clinicians, patient advocacy groups and the industrial sector.  This collaborative initiative is bridging the translational gap and improving commercialization of innovations

Visit the EpLink Website:


Watch the EpLink video:


EpLink publications: